FDA Investigator Charles J Chacko
Charles J Chacko has inspections in 7 countries as of 21 Aug 2023. Charles J Chacko has collaborated with a combined 2569 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
95
Last Inspection Date:
21 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
France,
China,
United Kingdom of Great Britain and Northern Ireland,
Germany,
Japan,
Ireland
Co-Investigator(s):
A Williams,
Addam S Reynolds,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Annette A Ragosta,
Anthony M Criscuolo, Jr,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Byungja E Marciante,
Cary Greene,
Cassandra Gasby,
Charles L Larson,
Cheryl A Grandinetti,
Chiang Syin, PhD,
Christina N Maurino,
Colin E Tack,
Craig W Swanson,
Daniel J Grabicki,
David H Smith,
Deborah B Nixon,
Demitria J Xiradakis,
Denise M Visco, Investigator,
Doreen P Canetti,
Doreen P Gubbay,
Dorothy J Denes,
Douglas C Kovacs,
Edward O'shaughnessy,
Edward Oshaughnessy,
Emest F Bizjak,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Esteban Beltran,
Frank A Boardwick,
Frank J Marciniak,
Frederick Razzaghi,
George Pyramides,
Gianine E Thompkins,
Gianine E Tompkins,
Gobiga Vanniyasingam,
Gregson A Joseph,
Guerlain Ulysse,
Haitao Li,
Harperd,
Helen Verdel,
Herrmann,
Jacqueline S Warner,
James D Planchon,
Jason M Sluzynski,
Jean M Kelahan,
Jeffrey J Ebersole,
Jennifer L Custodio,
Joan A Loreng,
Jogy George,
Jonathan Ho,
Jose M Cayuela,
Jose V Obando,
Joshua J Silvestri,
Joy Rkozlowski Klena,
Juanita P Versace,
Justine Tomasso,
K Gonzlez,
Karen E D'orazio,
Kassa Ayalew, MD,
Kazi Rafiquzzaman,
Keith M Reilly,
Kelli F Dobilas,
Kelly Doremus,
Kerry A Kurdilla,
King,
Kinh Q Mac,
Kris K Moore,
Krishnaiah Yellela,
Kristen E Rescigno,
Kristy A Zielny,
Laishan L Lam,
Lata C Mathew, PhD,
Lauren L Vajo,
Lawrence R Johnson,
Li Li,
Liatte Kreuger, PharmD,
Lisa Harlan,
Lisa Mathew,
Lori S Lawless,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Maria Manzoni, PhD,
Marjorie D Schultz,
Maryam Tabatabaie,
Matthew A Spataro,
Matthew W Kyle,
Mayar M Mussa,
Melanie W Pishnery,
Melba T Rivera,
Melba Trivera Clavell,
Melissa A Freeman,
Melissa A Zuppe,
Melissa B Libby,
Melissa T Roy,
Michael R Klapal,
Michael Serrano,
Miguel G Manzano,
Msdap Gonzlezk,
Naakesh N Gomanie,
Nancy F Scheraga,
Nicholas A Violand,
Niketa Patel,
Nina Yang,
Paul L Bellamy,
Peter R Lenahan,
Philip F Istafanos, DMV, MS,
Regina T Brown,
Remache,
Richard D Manney,
Robert G Ruff,
Robert W Jennings,
Rodney T Allnutt,
Ronald Ifraimov,
Russell J Glapion,
Sandra Kershaw,
Sarah Forney,
Schultz,
Shahla Parvizi,
Sherri J Liu,
Simone E Pitts,
Sinai Davis,
State Agency,
Stephanie T Durso,
Stephen J Mottola,
Steven M Weinman,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Bizjak,
Tara R Gooen,
Tonia F Bernard,
Toyin B Oladimeji,
Tressa T Lewis,
Tyanna N Hadley,
Tynna N Hadley,
Valerie C Reed,
Wayne J Meyer,
William R Chang,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu,
Zhugong Liu
Charles J Chacko's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more